COVID-19 Impact on Global Microscopic Polyangiitis (MPA) Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 93 pages | ID: C1EC7439D846EN
QYResearch

Abstracts

This report focuses on the global Microscopic Polyangiitis (MPA) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Microscopic Polyangiitis (MPA) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Celltrion Inc
• ChemoCentryx Inc
• Sandoz International GmbH
• Teijin Pharma Ltd
• TTY Biopharm Company Ltd

Market segment by Type, the product can be split into

• Avacopan
• Immune Globulin
• Rituximab Biosimilar
• Others

Market segment by Application, split into

• Hospital
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Microscopic Polyangiitis (MPA) Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Microscopic Polyangiitis (MPA) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Microscopic Polyangiitis (MPA) Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Microscopic Polyangiitis (MPA) Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Avacopan
  1.4.3 Immune Globulin
  1.4.4 Rituximab Biosimilar
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Microscopic Polyangiitis (MPA) Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Microscopic Polyangiitis (MPA) Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Microscopic Polyangiitis (MPA) Treatment Industry
    1.6.1.1 Microscopic Polyangiitis (MPA) Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Microscopic Polyangiitis (MPA) Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Microscopic Polyangiitis (MPA) Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Microscopic Polyangiitis (MPA) Treatment Market Perspective (2015-2026)
2.2 Microscopic Polyangiitis (MPA) Treatment Growth Trends by Regions
  2.2.1 Microscopic Polyangiitis (MPA) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Microscopic Polyangiitis (MPA) Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Microscopic Polyangiitis (MPA) Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Microscopic Polyangiitis (MPA) Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Microscopic Polyangiitis (MPA) Treatment Players by Market Size
  3.1.1 Global Top Microscopic Polyangiitis (MPA) Treatment Players by Revenue (2015-2020)
  3.1.2 Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Microscopic Polyangiitis (MPA) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Microscopic Polyangiitis (MPA) Treatment Market Concentration Ratio
  3.2.1 Global Microscopic Polyangiitis (MPA) Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Microscopic Polyangiitis (MPA) Treatment Revenue in 2019
3.3 Microscopic Polyangiitis (MPA) Treatment Key Players Head office and Area Served
3.4 Key Players Microscopic Polyangiitis (MPA) Treatment Product Solution and Service
3.5 Date of Enter into Microscopic Polyangiitis (MPA) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Microscopic Polyangiitis (MPA) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Type (2021-2026)

5 MICROSCOPIC POLYANGIITIS (MPA) TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)
5.2 Global Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020)
6.2 Microscopic Polyangiitis (MPA) Treatment Key Players in North America (2019-2020)
6.3 North America Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
6.4 North America Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020)
7.2 Microscopic Polyangiitis (MPA) Treatment Key Players in Europe (2019-2020)
7.3 Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
7.4 Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020)
8.2 Microscopic Polyangiitis (MPA) Treatment Key Players in China (2019-2020)
8.3 China Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
8.4 China Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020)
9.2 Microscopic Polyangiitis (MPA) Treatment Key Players in Japan (2019-2020)
9.3 Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
9.4 Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020)
10.2 Microscopic Polyangiitis (MPA) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020)
11.2 Microscopic Polyangiitis (MPA) Treatment Key Players in India (2019-2020)
11.3 India Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
11.4 India Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020)
12.2 Microscopic Polyangiitis (MPA) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Celltrion Inc
  13.1.1 Celltrion Inc Company Details
  13.1.2 Celltrion Inc Business Overview and Its Total Revenue
  13.1.3 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Introduction
  13.1.4 Celltrion Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020))
  13.1.5 Celltrion Inc Recent Development
13.2 ChemoCentryx Inc
  13.2.1 ChemoCentryx Inc Company Details
  13.2.2 ChemoCentryx Inc Business Overview and Its Total Revenue
  13.2.3 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Introduction
  13.2.4 ChemoCentryx Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
  13.2.5 ChemoCentryx Inc Recent Development
13.3 Sandoz International GmbH
  13.3.1 Sandoz International GmbH Company Details
  13.3.2 Sandoz International GmbH Business Overview and Its Total Revenue
  13.3.3 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Introduction
  13.3.4 Sandoz International GmbH Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
  13.3.5 Sandoz International GmbH Recent Development
13.4 Teijin Pharma Ltd
  13.4.1 Teijin Pharma Ltd Company Details
  13.4.2 Teijin Pharma Ltd Business Overview and Its Total Revenue
  13.4.3 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Introduction
  13.4.4 Teijin Pharma Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
  13.4.5 Teijin Pharma Ltd Recent Development
13.5 TTY Biopharm Company Ltd
  13.5.1 TTY Biopharm Company Ltd Company Details
  13.5.2 TTY Biopharm Company Ltd Business Overview and Its Total Revenue
  13.5.3 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Introduction
  13.5.4 TTY Biopharm Company Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
  13.5.5 TTY Biopharm Company Ltd Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Microscopic Polyangiitis (MPA) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Microscopic Polyangiitis (MPA) Treatment Revenue
Table 3. Ranking of Global Top Microscopic Polyangiitis (MPA) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Avacopan
Table 6. Key Players of Immune Globulin
Table 7. Key Players of Rituximab Biosimilar
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Microscopic Polyangiitis (MPA) Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Microscopic Polyangiitis (MPA) Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Microscopic Polyangiitis (MPA) Treatment Players to Combat Covid-19 Impact
Table 14. Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions (2015-2020)
Table 18. Global Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Microscopic Polyangiitis (MPA) Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Microscopic Polyangiitis (MPA) Treatment Players
Table 25. Global Microscopic Polyangiitis (MPA) Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Players (2015-2020)
Table 27. Global Top Microscopic Polyangiitis (MPA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microscopic Polyangiitis (MPA) Treatment as of 2019)
Table 28. Global Microscopic Polyangiitis (MPA) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Microscopic Polyangiitis (MPA) Treatment Product Solution and Service
Table 31. Date of Enter into Microscopic Polyangiitis (MPA) Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Microscopic Polyangiitis (MPA) Treatment Market Size Share by Type (2015-2020)
Table 35. Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Microscopic Polyangiitis (MPA) Treatment Market Size Share by Application (2015-2020)
Table 37. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Microscopic Polyangiitis (MPA) Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020)
Table 41. North America Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 43. North America Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020)
Table 47. Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 49. Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020)
Table 53. China Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 55. China Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020)
Table 59. Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 61. Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020)
Table 65. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020)
Table 71. India Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 73. India Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020)
Table 77. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 81. Celltrion Inc Company Details
Table 82. Celltrion Inc Business Overview
Table 83. Celltrion Inc Product
Table 84. Celltrion Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$)
Table 85. Celltrion Inc Recent Development
Table 86. ChemoCentryx Inc Company Details
Table 87. ChemoCentryx Inc Business Overview
Table 88. ChemoCentryx Inc Product
Table 89. ChemoCentryx Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$)
Table 90. ChemoCentryx Inc Recent Development
Table 91. Sandoz International GmbH Company Details
Table 92. Sandoz International GmbH Business Overview
Table 93. Sandoz International GmbH Product
Table 94. Sandoz International GmbH Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$)
Table 95. Sandoz International GmbH Recent Development
Table 96. Teijin Pharma Ltd Company Details
Table 97. Teijin Pharma Ltd Business Overview
Table 98. Teijin Pharma Ltd Product
Table 99. Teijin Pharma Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$)
Table 100. Teijin Pharma Ltd Recent Development
Table 101. TTY Biopharm Company Ltd Company Details
Table 102. TTY Biopharm Company Ltd Business Overview
Table 103. TTY Biopharm Company Ltd Product
Table 104. TTY Biopharm Company Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$)
Table 105. TTY Biopharm Company Ltd Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Avacopan Features
Figure 3. Immune Globulin Features
Figure 4. Rituximab Biosimilar Features
Figure 5. Others Features
Figure 6. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Microscopic Polyangiitis (MPA) Treatment Report Years Considered
Figure 11. Global Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Players in 2019
Figure 16. Global Top Microscopic Polyangiitis (MPA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microscopic Polyangiitis (MPA) Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Microscopic Polyangiitis (MPA) Treatment Revenue in 2019
Figure 18. North America Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Celltrion Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Celltrion Inc Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 27. ChemoCentryx Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. ChemoCentryx Inc Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 29. Sandoz International GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Sandoz International GmbH Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 31. Teijin Pharma Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Teijin Pharma Ltd Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 33. TTY Biopharm Company Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. TTY Biopharm Company Ltd Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed